(Q52026171)

20 April 2018

title

Interaction of topiramate with conventional antiepileptic drugs in mice. (English)

1 reference

20 April 2018

4

Z Kleinrok

1 reference

20 April 2018

Stanisław Jerzy Czuczwar

5

object named as

S J Czuczwar

1 reference

20 April 2018

Mariusz Swiader

1

object named as

M Swiader

1 reference

20 April 2018

author name string

J Kotowski

2

1 reference

20 April 2018

M Gasior

3

1 reference

20 April 2018

language of work or name

English

0 references

publication date

1 June 2000

1 reference

20 April 2018

European Journal of Pharmacology

published in

1 reference

20 April 2018

volume

399

1 reference

20 April 2018

issue

1

1 reference

20 April 2018

page(s)

35-41

1 reference

20 April 2018

Expanding antiepileptic drug options: clinical efficacy of new therapeutic agents

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900365-4

The non-competitive AMPA/kainate receptor antagonist, GYKI 52466, potentiates the anticonvulsant activity of conventional antiepileptics.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900365-4

Competitive NMDA-receptor antagonists, LY 235959 and LY 233053, enhance the protective efficacy of various antiepileptic drugs against maximal electroshock-induced seizures in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900365-4

Influence of LY 300164, an antagonist of AMPA/kainate receptors, on the anticonvulsant activity of clonazepam

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900365-4

Low propensity of conventional antiepileptic drugs for interaction with felbamate against maximal electroshock-induced seizures in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900365-4

Drug interaction profile of topiramate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900365-4

New antiepileptic drugs: comparison of key clinical trials.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900365-4

Effect of aminophylline upon the protective activity of common antiepileptic drugs and their plasma levels in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900365-4

LY 300164, a novel antagonist of AMPA/kainate receptors, potentiates the anticonvulsive activity of antiepileptic drugs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900365-4

A double-blind, randomized trial of topiramate as adjunctive therapy for partial-onset seizures in children. Topiramate YP Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900365-4

Clobazam, oxcarbazepine, tiagabine, topiramate, and other new antiepileptic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900365-4

Clinical efficacy of new antiepileptic drugs in refractory partial epilepsy: experience in the United States with three novel drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900365-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900365-4

Pharmacokinetics of new antiepileptic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900365-4

Topiramate increases cerebral GABA in healthy humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900365-4

New visions in the pharmacology of anticonvulsion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900365-4

Which animal models should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical considerations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900365-4

Antiepileptic drug actions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900365-4

Update on the mechanism of action of antiepileptic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900365-4

Topiramate for intractable childhood epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900365-4

Antiepileptic drugs. A review of clinically significant drug interactions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900365-4

Pharmacokinetic profile of topiramate in comparison with other new antiepileptic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900365-4

Sodium channels as molecular targets for antiepileptic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900365-4

A double-blind, randomized trial of topiramate in Lennox-Gastaut syndrome. Topiramate YL Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900365-4

Topiramate: preclinical evaluation of structurally novel anticonvulsant.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900365-4

Safety of topiramate: adverse events and relationships to dosing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900365-4

Ionic mechanisms of neuronal excitation by inhibitory GABAA receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900365-4

Clinical experiences with topiramate in children with intractable epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900365-4

Benzodiazepine impairs and beta-carboline enhances performance in learning and memory tasks

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900365-4

Topiramate attenuates voltage-gated sodium currents in rat cerebellar granule cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900365-4

10.1016/S0014-2999(00)00365-4

7 January 2021

Identifiers

DOI

1 reference

20 April 2018

1 reference

20 April 2018